Cardio-Thoracic-Vascular Department, San Raffaele Hospital, Milan, Italy.
Int J Cardiol. 2013 Sep 30;168(2):1402-9. doi: 10.1016/j.ijcard.2012.12.044. Epub 2013 Jan 12.
Limited data are available on clinical outcome of patients with previously failed or not attempted chronic total occlusion (CTO) recanalization by percutaneous coronary intervention (PCI). The aim of the study is to determine prevalence and predictors of cardiac death in patients with CTO not revascularized by PCI.
Double-center study analyzing data of 1.345 consecutive patients with at least one CTO between 1998 and 2008. Of these, 847 patients were successfully revascularized (Revascularized group) and 498 patients were not revascularized (Not revascularized group) either due to failure of CTO-PCI (n=337) or because no attempt was made (n=161).
At 4-year clinical follow-up, Not revascularized patients had a significantly higher rate of cardiac mortality (8.5% vs. 2.5%, p<0.0001) and sudden cardiac death (2.7% vs. 0.5%, p=0.001) compared to those Revascularized. The separate adjusted Cox-model analysis made for Not revascularized patients showed the most significant independent predictors of cardiac death were: chronic renal failure [HR (CI), 6.0 (2.66-13.80)], low-LVEF [5.7 (2.84-11.58)], insulin-dependent diabetes mellitus (IDDM) 4.6 [(1.96-10.97)]. In the Revascularized group, the presence of 3-vessel disease was the only significant independent predictor of cardiac death [4.4 (1.40-13.70)].
CTO patients Not revascularized had a significant higher rate of cardiac mortality and sudden cardiac death compared to those Revascularized. Within Not revascularized patients, the presence of low-LVEF, or CRF or IDDM was associated with an incidence of cardiac death at least 4 times higher than those without the same risk factors.
经皮冠状动脉介入治疗(PCI)治疗失败或未尝试慢性完全闭塞(CTO)再通的患者的临床转归数据有限。本研究旨在确定未接受 PCI 血运重建的 CTO 患者的心脏死亡发生率和预测因素。
这是一项分析 1998 年至 2008 年间至少有一条 CTO 的 1345 例连续患者数据的双中心研究。其中,847 例患者血运重建成功(血运重建组),498 例患者因 CTO-PCI 失败(n=337)或未尝试(n=161)而未血运重建(未血运重建组)。
在 4 年临床随访中,未血运重建组的心脏死亡率(8.5%比 2.5%,p<0.0001)和心脏性猝死率(2.7%比 0.5%,p=0.001)明显高于血运重建组。对未血运重建患者进行的单独校正 Cox 模型分析显示,心脏死亡的独立预测因素有:慢性肾功能衰竭[HR(CI),6.0(2.66-13.80)]、低左心室射血分数[5.7(2.84-11.58)]、胰岛素依赖型糖尿病(IDDM)4.6(1.96-10.97)]。在血运重建组中,3 支血管病变是心脏死亡的唯一独立预测因素[4.4(1.40-13.70)]。
与血运重建组相比,未血运重建的 CTO 患者的心脏死亡率和心脏性猝死率明显更高。在未血运重建患者中,低左心室射血分数、慢性肾功能衰竭或 IDDM 的存在与心脏死亡发生率至少增加 4 倍相关,而无这些危险因素的患者则不会发生心脏死亡。